Sarah Schaffer DeRoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah Schaffer DeRoo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Linda Y. Fu
2 shared publicationsBeth A. Tarini
Children’s National Hospital
1 shared publication- Honora Quinn Burnett
Denver Health and University of Colorado School of Medicine, 777 Bannock Street, Denver, CO 80204, USA
1 shared publication Jennifer Jiggetts
1 shared publicationJessica Lazerov
Division of General and Community Pediatrics, Children’s National Hospital, Washington, DC
1 shared publicationNatalie J. Pudalov
The George Washington University School of Medicine and Health Sciences, Washington, DC
1 shared publication
Latest Publications
- 6 May 2026
- Published by SAGE Publications in American Journal of Health Promotion
Differences in Parents’ Perspectives on Pediatric COVID-19 Vaccination by Child’s Age
Purpose: Uptake of Coronavirus Disease 2019 (COVID-19) vaccines among children has been lackluster with significant disparities by age. We explored how child’s age influences parental COVID-19 vaccine decision making. Design: Semi-structured interviews were conducted using a phenomenological approach. Setting: A network of five outpatient pediatric clinics. Participants: Parents of children <18 years old presenting for well or sick telemedicine visits. Method: We conducted a focused analysis of themes by age groups with different vaccine doses and recommendations: 6 months to 4 years, 5 to 11 years, and 12 to 17 years. Results: We interviewed 26 parents between June 2022 and January 2023. Fourteen (54%) interviewees had a child ≤4 years old, 16 (62%) had a child 5 to 11 years old, and 8 (31%) had a child ≥12 years old. Factors related to three broad themes contributed to age-specific differences in COVID-19 vaccine decision making: (1) perceptions about COVID-19 infection risk; (2) perceptions about COVID-19 vaccine safety; and (3) logistical considerations. Conclusion: Several factors influencing age-specific COVID-19 vaccine uptake during rollout continue to hinder vaccine uptake among children. Logistical barriers – specifically supply shortages and availability – that impeded the COVID-19 vaccine rollout for the youngest children also hindered the recent RSV immunization promotion efforts. Lessons learned from our study should inform ongoing vaccine promotion efforts, new vaccine rollouts, and pandemic preparedness.
- 6 May 2026
- Published by SAGE Publications in American Journal of Health Promotion
Differences in Parents’ Perspectives on Pediatric COVID-19 Vaccination by Child’s Age
Purpose: Uptake of Coronavirus Disease 2019 (COVID-19) vaccines among children has been lackluster with significant disparities by age. We explored how child’s age influences parental COVID-19 vaccine decision making. Design: Semi-structured interviews were conducted using a phenomenological approach. Setting: A network of five outpatient pediatric clinics. Participants: Parents of children <18 years old presenting for well or sick telemedicine visits. Method: We conducted a focused analysis of themes by age groups with different vaccine doses and recommendations: 6 months to 4 years, 5 to 11 years, and 12 to 17 years. Results: We interviewed 26 parents between June 2022 and January 2023. Fourteen (54%) interviewees had a child ≤4 years old, 16 (62%) had a child 5 to 11 years old, and 8 (31%) had a child ≥12 years old. Factors related to three broad themes contributed to age-specific differences in COVID-19 vaccine decision making: (1) perceptions about COVID-19 infection risk; (2) perceptions about COVID-19 vaccine safety; and (3) logistical considerations. Conclusion: Several factors influencing age-specific COVID-19 vaccine uptake during rollout continue to hinder vaccine uptake among children. Logistical barriers – specifically supply shortages and availability – that impeded the COVID-19 vaccine rollout for the youngest children also hindered the recent RSV immunization promotion efforts. Lessons learned from our study should inform ongoing vaccine promotion efforts, new vaccine rollouts, and pandemic preparedness.
- Open Access
- 1 July 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (7) , e2520440
Nirsevimab Uptake in a Pediatric Primary Care Network During the 2023-2024 RSV Season
This cohort study characterizes nirsevimab uptake among infants who did and did not receive the respiratory syncytial virus (RSV) vaccine during the 2023 to 2024 RSV season.
- 1 July 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (7) , e2520440
Open AccessNirsevimab Uptake in a Pediatric Primary Care Network During the 2023-2024 RSV Season
This cohort study characterizes nirsevimab uptake among infants who did and did not receive the respiratory syncytial virus (RSV) vaccine during the 2023 to 2024 RSV season.
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization
- 1 August 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (8) , e2429612
Culturally Aware Vaccine Promotion to Prevent Outbreaks
The recurrence of outbreaks of vaccine-preventable diseases in close-knit, underimmunized communities in the US underscores the importance of effective
- 1 August 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (8) , e2429612
Culturally Aware Vaccine Promotion to Prevent Outbreaks
The recurrence of outbreaks of vaccine-preventable diseases in close-knit, underimmunized communities in the US underscores the importance of effective
- 31 August 2022
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 28 (6) , 595-598
Disciplining Physicians Who Spread Medical Misinformation
- 31 August 2022
- Published by Wolters Kluwer Health in Journal of Public Health Management & Practice
- Vol. 28 (6) , 595-598
Disciplining Physicians Who Spread Medical Misinformation
- 21 October 2021
- Published by Ethnicity and Disease Inc in Ethnicity & Disease
- Vol. 31 (4) , 519-526
Attitudes about COVID-19 Testing among Black Adults in the United States
Purpose: Black Americans are disproportionately affected by coronavirus disease 2019 (COVID-19) hospitalizations and deaths. Decreasing health disparities requires widespread uptake of COVID-19 testing, but attitudes about COVID-19 testing among Black Americans have not been studied. We aimed to characterize knowledge, attitudes, and beliefs about COVID-19 testing among Black parents.Methods: Semi-structured interviews were conducted and analyzed using a phenomenology approach with 26 self-identified Black parents after telemedicine visits with a children’s health center. Interviews were recorded and transcribed; 65% were double coded with a resultant free-marginal interrater kappa score of 86.8%.Results: Most participants were women, spent time inside the homes of friends or family members, and almost half knew someone diagnosed with COVID-19. Three central themes emerged regarding COVID-19 testing decision making, including: 1) perceived COVID-19 disease susceptibility; 2) barriers to testing, with subthemes including trust in test accuracy and safety, perceived stigma of a positive test result, and impact of racism on self-efficacy; and 3) cues to action.Conclusions: When considering these themes as constructs of the Health Belief Model, we are better able to understand Black Americans’ views of COVID-19 testing and motivations for accessing testing. Culturally responsive educational campaigns delivered by trusted community members should aim to improve understanding about disease transmission and types of tests available. Importantly, framing testing as a means to ensure safety may improve self-efficacy to obtain testing. Lastly, the health community should learn from these conversations with Black Americans so that disease prevention and mitigation strategies prioritize health equity. Ethn Dis. 2021;31(4):519-526; doi:10.18865/ed.31.4.519
- 21 October 2021
- Published by Ethnicity and Disease Inc in Ethnicity & Disease
- Vol. 31 (4) , 519-526
Attitudes about COVID-19 Testing among Black Adults in the United States
Purpose: Black Americans are disproportionately affected by coronavirus disease 2019 (COVID-19) hospitalizations and deaths. Decreasing health disparities requires widespread uptake of COVID-19 testing, but attitudes about COVID-19 testing among Black Americans have not been studied. We aimed to characterize knowledge, attitudes, and beliefs about COVID-19 testing among Black parents.Methods: Semi-structured interviews were conducted and analyzed using a phenomenology approach with 26 self-identified Black parents after telemedicine visits with a children’s health center. Interviews were recorded and transcribed; 65% were double coded with a resultant free-marginal interrater kappa score of 86.8%.Results: Most participants were women, spent time inside the homes of friends or family members, and almost half knew someone diagnosed with COVID-19. Three central themes emerged regarding COVID-19 testing decision making, including: 1) perceived COVID-19 disease susceptibility; 2) barriers to testing, with subthemes including trust in test accuracy and safety, perceived stigma of a positive test result, and impact of racism on self-efficacy; and 3) cues to action.Conclusions: When considering these themes as constructs of the Health Belief Model, we are better able to understand Black Americans’ views of COVID-19 testing and motivations for accessing testing. Culturally responsive educational campaigns delivered by trusted community members should aim to improve understanding about disease transmission and types of tests available. Importantly, framing testing as a means to ensure safety may improve self-efficacy to obtain testing. Lastly, the health community should learn from these conversations with Black Americans so that disease prevention and mitigation strategies prioritize health equity. Ethn Dis. 2021;31(4):519-526; doi:10.18865/ed.31.4.519
- Top Cited PapersOpen Access
- 23 June 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (24) , 2458-2459
Planning for a COVID-19 Vaccination Program
This Viewpoint describes the categories of concerns underlying vaccine hesitancy (necessity, safety, and freedom of choice), and proposes ways to educate the pu
- 23 June 2020
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (24) , 2458-2459
Top Cited PapersOpen AccessPlanning for a COVID-19 Vaccination Program
This Viewpoint describes the categories of concerns underlying vaccine hesitancy (necessity, safety, and freedom of choice), and proposes ways to educate the pu